IIT: Ph2 Home Care Study Autologous Hematopoietic Stem Cell Transplantation

Purpose of this Study

We are doing this study to compare the outcomes of people who get their after-transplant care in the hospital versus in their home. This study is important to learn if getting after-transplant care in a patient's home can lead to better outcomes.

Who Can Participate?

Eligibility

Adults ages18-80 who:<ul>
<li>Are scheduled to get an autologous stem cell transplant for any type of illness</li>
<li>Are able to read and write in English</li>
<li>Have a home that is close to Duke, or are staying in approved temporary lodging (e.g., hotel) that is close to Duke</li></ul>
The caregivers of people receiving these transplants can also participate.

For more information about who can join this study, please contact the study team at andrea.pires@duke.edu or 919-668-4978.

Age Range

18-80

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

If you choose to join the study, you will:<ul>
<li>Be randomly assigned (like a coin flip) to either get your after-transplant care in the hospital or in your home/temporary lodging</li>
<li>Fill out questionnaires</li>
<li>Collect home surface samples</li>
<li>Give stool samples</li>
<li>Have your skin swabbed</li>
<li>Have blood draws</li>
<li>Do hand grip tests and 6-minute walk tests</li>
<li>Complete cognitive function tests</li>
<li>Use an Apple Watch and iPhone to track your activity and complete daily entries in an app</li></ul>
If your caregiver chooses to join the study, they will:
<li>Fill out questionnaires</li>
<li>Collect home surface samples</li>
<li>Give stool samples</li>
<li>Have their skin swabbed</li></ul>

Locations

Duke University Hospital
Other

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Principal Investigator

Nelson
Chao

Protocol Number

PRO00089697

NCT ID

NCT03667599

Phase

II

Enrollment Status

Open to Enrollment